Seelos Therapeutics (SEEL) Fair Value & DCF
SEEL fair value $1.71. Price $0.37. Price is 78% below fair value.
Worked example
No cash-flow value. Free cash flow is not steady enough to discount.
Earnings value. Next-twelve-months earnings per share of $0.06 times 28.43 is $1.71. The peer group is Biotechnology, 13 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 28.4 is kept between 8 and 30, which is 28.43.
Fair value is the earnings value, $1.71. The price is $0.37, which is 78.3% below fair value.